ANDO DALE G

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
37
Insider Sells Sum
$5.73M

Insider Activity of ANDO DALE G

The largest sale of all time was on 2014-02-26 and amounted to 15000 shares of Sangamo Therapeutics, Inc. for $295,752.

Biography of ANDO DALE G

No biography is available at this moment.

2015-06-05SaleSangamo Therapeutics, Inc.
SGMO
VP, Therapeutic Dev. & CMO
15,000
0.0211%
$12.29$184,394-43.86%
2015-05-05SaleSangamo Therapeutics, Inc.
SGMO
VP, Therapeutic Dev. & CMO
15,000
0.0216%
$12.29$184,298-39.62%
2015-04-06SaleSangamo Therapeutics, Inc.
SGMO
VP, Therapeutic Dev. & CMO
15,000
0.0216%
$14.94$224,172-47.79%
2015-03-05SaleSangamo Therapeutics, Inc.
SGMO
VP, Therapeutic Dev. & CMO
15,000
0.0219%
$18.29$274,283-51.19%
2015-02-05SaleSangamo Therapeutics, Inc.
SGMO
VP, Therapeutic Dev. & CMO
15,000
0.0214%
$12.93$193,950-29.09%
2015-01-05SaleSangamo Therapeutics, Inc.
SGMO
VP, Therapeutic Dev. & CMO
15,000
0.0218%
$15.19$227,854-32.89%
2014-12-05SaleSangamo Therapeutics, Inc.
SGMO
VP, Therapeutic Dev. & CMO
15,000
0.0221%
$11.21$168,197+5.73%
2014-11-05SaleSangamo Therapeutics, Inc.
SGMO
VP, Therapeutic Dev. & CMO
15,000
0.0228%
$11.35$170,258+9.61%
2014-10-06SaleSangamo Therapeutics, Inc.
SGMO
VP, Therapeutic Dev. & CMO
15,000
0.0225%
$10.72$160,865+14.88%
2014-09-05SaleSangamo Therapeutics, Inc.
SGMO
VP, Therapeutic Dev. & CMO
15,000
0.0217%
$12.20$183,072-0.53%
2014-08-05SaleSangamo Therapeutics, Inc.
SGMO
VP, Therapeutic Dev. & CMO
15,000
0.021%
$12.99$194,846-6.95%
2014-05-27SaleSangamo Therapeutics, Inc.
SGMO
VP, Therapeutic Dev. & CMO
15,000
0.0221%
$13.57$203,531-1.11%
2014-04-28SaleSangamo Therapeutics, Inc.
SGMO
VP, Therapeutic Dev. & CMO
15,000
0.0224%
$13.64$204,532+0.67%
2014-03-26SaleSangamo Therapeutics, Inc.
SGMO
VP, Therapeutic Dev. & CMO
15,000
0.0243%
$18.65$279,695-25.82%
2014-02-26SaleSangamo Therapeutics, Inc.
SGMO
VP, Therapeutic Dev. & CMO
15,000
0.0244%
$19.72$295,752-29.53%
2014-01-27SaleSangamo Therapeutics, Inc.
SGMO
VP, Therapeutic Dev. & CMO
15,000
0.0238%
$18.58$278,729-25.76%
2013-12-26SaleSangamo Therapeutics, Inc.
SGMO
VP, Therapeutic Dev. & CMO
15,000
0.0272%
$14.37$215,477-2.76%
2013-11-26SaleSangamo Therapeutics, Inc.
SGMO
VP, Therapeutic Dev. & CMO
15,000
0.0269%
$11.83$177,378+15.11%
2013-10-28SaleSangamo Therapeutics, Inc.
SGMO
VP, Therapeutic Dev. & CMO
3,000
0.0052%
$10.39$31,156+27.8%
2013-09-26SaleSangamo Therapeutics, Inc.
SGMO
VP, Therapeutic Dev. & CMO
15,000
0.0268%
$10.57$158,574+25.79%
Company
About Prismo.proPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.